ABOUT

Diversity, Equity & Inclusion Resources

AMP has assembled a list of available resources on diversity, equity, & inclusion. This page will change as new information becomes available. Check back frequently for updates. Please send suggestions for additional resources to dei@amp.org.


AMP

NCI

NCI Cancer Moonshot Scholars Program Seeks to Diversify R01 Portfolio

The Cancer Moonshot Scholars program seeks to diversify the NCI R01 portfolio by enhancing the number of applications submitted by Early Stage Investigators from diverse backgrounds, including those from groups identified as underrepresented (NOT-OD-20-031) in the biomedical, clinical, behavioral, and social sciences research workforce. Proposed research must align with the NCI’s mission and may address any of the broad areas of cancer research, including (but not limited to) cancer biology, cancer prevention, cancer diagnosis, cancer treatment, and cancer control. Basic, translational, clinical, and/or population-based studies in all these research areas are appropriate. NCI expects to fund approximately 45 new R01s during the next 3 years. The program due dates are November 8, 2022, June 6, 2023, and February 6, 2024.

The Diversity Movement (TDM) Consulting Team

University of Southern California

Other Resources

Coalition for Diversity & Inclusion in Scholarly Communications (C4DISC)


Disclaimer: With the exception of resources labeled above as having been generated by AMP,  links will take you to external websites. Resources above are the sole responsibility of the entity providing them. AMP does not endorse any commercial product or service. AMP makes no warranty, express or implied, regarding any commercial product or service, and hereby disclaims, the accuracy, completeness, timeliness or merchantability or fitness for a particular purpose of the content and associated materials presented above. AMP shall not be liable for any damages, including direct, indirect, special, incidental, or consequential or any other type of damages arising out of or related to the use of the information contained on this page or associated materials.

Corporate Partners